Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.

By P. Zandi, M. Carlson, B. Plassman, Kathleen Welsh-Bohmer, L. Mayer, D. Steffens, J. Breitner. Journal of the American Medical Association (JAMA), 2002

886 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Psychiatry and Mental health, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/36cd0c1d170b62458c5c8a9dd6f8c86000a8bc24

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Arno Villringer
2. R. Anand
3. K. Gill
4. A. Mahdi
5. J. Sacher
6. C. Barth

Citations in the corpus

• Therapeutics of Alzheimer's disease: Past, present and future. (2014, background): “The role of hormone replacement therapy (HRT) is still controversial; studies indicate that prior use of HRT decreases the risk of AD in women, but current use is not useful unless used more than 10 years (Zandi et al., 2002).”
• Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods (2015, background): “When estrogen therapy is used early in menopausal transition, it can protect against dementia (Zandi et al., 2002).”
• Understanding the impact of sex and gender in Alzheimer's disease: A call to action (2018, neutral): “[134] Zandi PP, CarlsonMC, Plassman BL,Welsh-Bohmer KA,Mayer LS,”